Clinical Papers & Posters.

NETosis and Nucleosome Biomarkers in Septic Shock & Critical COVID-19 Patients

ISTH 2022: Evaluation and comparison of NETosis biomarkers in sepsis and COVID-19 patients

High specificity lung cancer test to rule out cancer in non-malignant lung nodules found at LDCT.

Circulating nucleosomes to identify non-smoker subjects at risk of lung cancer and triage them for low-dose CT scan.

Circulating nucleosomes predict response to tyrosine kinase inhibitors in hepatocellular carcinoma

Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib

Nu.Q® Capture-MS allows the epigenetic profile analysis of circulating nucleosomes in non-Hodgkin lymphoma patients

Circulating nucleosomes levels improve FIT performance for detecting high-risk colorectal neoplasms in a symptomatic population.

Circulating nucleosomes for Detection of Colorectal Cancer and High risk Advanced Adenomas

Identifying tools to track hypercoagulability in COVID-19 patients: Exploring global haemostasis (ROTEM) and neutrophil extracellular traps (NETs) immunoassays

Circulating Nucleosome Immunoassay: Evaluating a Clinically-Applicable Test to Risk Stratify COVID-19 and Target Anticoagulation

Serial profiling of cell‑free DNA and nucleosome histone modifications in cell cultures

A Novel Proteomics Approach to Epigenetic Profiling of Circulating Nucleosomes

Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression

Therapeutic Removal of NETs from Blood in a Pig Model of Sepsis

Circulating nucleosomes in hematological malignancy ASCO 2020

Performance of a Nu.Q H3.1 assay for lung cancer detection ASCO 2020

Enrichment of circulating tumor DNA from cell-free DNA of hematopoietic origin ASCO 2020

Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve